Article Details
Retrieved on: 2018-02-06 20:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The round also witnessed the participation of Aisling, Eventide, Morningside, Brace Pharma Capital, Morningside and Leerink Partners with existing investors SV Health Investors, <b>Atlas Venture</b>, and Clarus Ventures. With the proceeds from the financing, Avrobio says that it will soon commence its Phase ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here